SME Times is powered by   
Search News
Just in:   • PM Modi inaugurates ESTIC 2025, launches Rs one lakh crore RDI Scheme Fund  • FM Sitharaman embarks on Bhutan visit to deepen economic, developmental cooperation  • Trump, Xi agree on one-year rare earth supply deal amid easing trade tensions  • Adding more women in STEM sectors imperative for Viksit Bharat vision  • Indian Airforce team to dazzle skies over Statue of Unity on Rashtriya Ekta Diwas 
Last updated: 18 Jul, 2017  

Exports.9.Thmb.jpg 'Pharma exports drop by 8.5 pc to $2.5 bn'

india-pharma-industry.jpg
   Top Stories
» PM Modi inaugurates ESTIC 2025, launches Rs one lakh crore RDI Scheme Fund
» FM Sitharaman embarks on Bhutan visit to deepen economic, developmental cooperation
» Trump, Xi agree on one-year rare earth supply deal amid easing trade tensions
» Adding more women in STEM sectors imperative for Viksit Bharat vision
» US Fed rate cut clear signal for RBI to follow suit in next MPC: Experts
Saurabh Gupta | 18 Jul, 2017
Due to pricing pressure and stiff competition, the Pharma exports from India during April-May 2017 fell by 8.5 percent to USD 2.5 billion, said a report by Care Ratings.

"The prime reasons for the weak exports were price erosion in the generic market in USA due to consolidation among customers i.e. the distribution channels, increase in competition, absence of blockbuster drugs going off patent and regulatory issues faced by Indian Pharma companies," the report said, released Monday.


This situation continued even during the initial months of the current financial year 2017-18 and exports to USA declined by 23 percent y-o-y to USD 723.4 million during April-May 2017. The total exports from India during the  same period fell by 8.5 percent to USD 2.5 billion," it added.


Of the total exports of USD 16.8 billion during the year 2016
-17, majority of the exports, accounting for 40.6 percent were to the American continent followed by 19.7 percent to Europe, 19.1 percent to Africa and 18.8 percent within Asia.


Among the countries, United States of America is the primar
y export destination for India. Exports to USA have been on a rise since more than a decade. The exports are mainly driven by the cost advantage that India has.


The share of exports to USA in total
drugs & pharma exports from India which was 25.4 percent in 2012 - 13 increased to 33.1 percent in 2016 - 17. For other countries like UK, South Africa, Nigeria, Russia, Brazil, Germany, Australia, the share of each of these countries in total drugs & pharma exports remained in the range of 1.4 percent - 3.3 percent in 2016-17.


In 2012
- 13, exports to USA grew by 14.2 percent y-o-y to USD 3.7 billion and increased in single digit in each of the following two years. In 2015-16, exports to USA surged by 27.8 percent to USD 5.5 billion on a y-o-y basis.


However, the export scenario to USA weakened and it grew by a marginal 1.3 percent to USD 5.6 billion in 2016
- 17, it added.
 
Print the Page Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
₹88.70
₹87
UK Pound
₹119.90
₹116
Euro
₹104.25
₹100.65
Japanese Yen ₹59.20 ₹57.30
As on 30 Oct, 2025
  Daily Poll
Who do you think will benefit more from the India - UK FTA in the long run?
 Indian businesses & consumers.
 UK businesses & consumers.
 Both will gain equally.
 The impact will be negligible for both.
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter